HTFL — Heartflow, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1464521 ·
Last close
$26.72
Market Cap
$2.30B
52W High
$36.46
52W Low
$24.77
ADV30
1,869,989
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 52,587,000 | 42,164,000 | -22,022,000 | -27,380,000 | 344,025,000 | 19,671,000 | 58,307,000 |
| Dec 2025 | 49,130,000 | 39,063,000 | -17,750,000 | -24,395,000 | 359,452,000 | 44,776,000 | 58,805,000 |
| Sep 2025 | 46,276,000 | 35,415,000 | -15,099,000 | -50,855,000 | 364,398,000 | 291,167,000 | 109,830,000 |
| Jun 2025 | 43,424,000 | 32,778,000 | -13,715,000 | -9,196,000 | 159,363,000 | 80,210,000 | 1,054,158,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,961,000
Investing CF
$-238,894,000
Financing CF
$219,278,000
CapEx
$-5,813,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.76
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,115,130,000
Inventory
—
Receivables
$35,527,000
ST Investments
$138,645,000
EBIT TTM
$-101,796,000
Pretax Income TTM
$-111,879,000
Interest Exp TTM
$10,083,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$191,416,000
EBITDA
$-67,195,000
Free Cash Flow
$-48,654,124
Enterprise Value
$2,258,628,864
Total Cash
$158,316,000
Total Debt
$26,349,000
Shares Out
86,240,828
Trailing EPS
$-3.09
Book Value
$3.32
ROE
-135.3%
ROA
-16.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 176,034,000 | -64,066,000 | -116,791,000 | 359,452,000 | 58,805,000 | — | -54,023,000 |
| Dec 2024 | 125,808,000 | -61,222,000 | -96,426,000 | 118,704,000 | 978,188,000 | — | -69,001,000 |
| Dec 2023 | 87,174,000 | -72,914,000 | -95,655,000 | 185,051,000 | 962,615,000 | — | -76,434,000 |
TTM Snapshot
Revenues TTM
$32,934,000
NetIncome TTM
$-19,140,000
OpCashFlow TTM
$0
Assets (Latest)
$118,704,000
Forward EPS
$-0.26
Max Pain — expiry 2027-01-15
max pain strike: $40.00 · spot: $26.72 · call oi: 1,233 · put oi: 118
Expected Move to 2027-01-15:
±$16.00
(59.88%) —
implied range
$10.72 –
$42.72
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LMAT | LEMAITRE VASCULAR INC | $2.35B | $102.74 | — |
| XRAY | DENTSPLY SIRONA Inc. | $2.46B | $12.26 | — |
| AXGN | Axogen, Inc. | $2.16B | $40.58 | — |
| TMDX | TransMedics Group, Inc. | $2.46B | $71.23 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.59B | $88.03 | — |
News headlines (Yahoo Finance, 1h cache)
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
2026-07-09 12:00 · Yahoo
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
2026-07-08 21:41 · Yahoo
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-07-04 14:04 · Yahoo
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
2026-06-24 19:05 · Yahoo
A Look At HeartFlow (HTFL) Valuation As Analyst Fair Value Diverges From Current Share Price
2026-06-07 03:19 · Yahoo
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?
2026-05-31 06:02 · Yahoo
HeartFlow Inc (HTFL) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and Raised ...
2026-05-15 05:02 · Yahoo
Heartflow Q1 Earnings Call Highlights
2026-05-15 01:08 · Yahoo
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
2026-05-14 20:01 · Yahoo
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.
2026-05-08 14:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.